Summary of Classification and Labelling
Notified classification and labelling
General Information
600-270-5 |
5-[3-[(1S)-2-(difluoromethoxy)-1-methylethoxy]-5-[[(5-methyl-2-pyrazinyl)amino]carbonyl]phenoxy]-N,N-dimethyl- 2-pyrazinecarboxamide |
1020668-59-0 |
Notified classification and labelling according to CLP criteria
Acute Tox. 4 |
H302
|
H302
|
|
GHS08 GHS07 Dgr
|
|
|
|
|
3 |
|
View details
|
Repr. 1B |
H360
(H360D)
|
H360
(H360D)
|
STOT RE 2 |
H373
(Adrenal glands,...)
(oral)
|
H373
|
STOT RE 2 |
H373
(other:Adrenal g...)
(oral)
|
H373
|
Number of Aggregated Notifications: 1